Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.
his is not a financial advice!
1 upcoming catalyst on 30rd of June 2024
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Shs. Float of 2.39M Massive Volume recentley - Rel. Vol. of 32.52
Keep an eye on 0.6, 0.85, 1.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.